A carregar...
Targeting FLT3 to treat leukemia
INTRODUCTION: Approximately 23% of acute myeloid leukemia (AML) patients younger than 60 years of age carry a mutation in the transmembrane domain of the FMS-like tyrosine kinase-3 (FLT3) gene (FLT3/internal tandem duplications [ITD]). In normal karyotype AML, the presence of a FLT3/ITD mutation is...
Na minha lista:
| Publicado no: | Expert Opin Ther Targets |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4697275/ https://ncbi.nlm.nih.gov/pubmed/25231999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.2014.960843 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|